{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:06:43Z","timestamp":1790251603201,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.07.027","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:55:59Z","timestamp":1786492559000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Bayesian Survival Model to Support the Selection of the Best Hematopoietic Stem Cell Donor"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8473-202X","authenticated-orcid":false,"given":"Roberto","family":"Crocchiolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-6276","authenticated-orcid":false,"given":"Stefania","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7954-0231","authenticated-orcid":false,"given":"Davide","family":"Chizzoniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6239-7387","authenticated-orcid":false,"given":"Luca","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-130X","authenticated-orcid":false,"given":"Michele","family":"Malagola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5908-0792","authenticated-orcid":false,"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6297-9697","authenticated-orcid":false,"given":"Nicola","family":"Polverelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rombol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-401X","authenticated-orcid":false,"given":"Nicoletta","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirico","family":"Semeraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.07.027_bib0001","first-page":"1529","article-title":"Antileukemic effect of chronic graft-versus-host disease","volume":"304","author":"Weiden","year":"1981"},{"key":"10.1016\/j.jtct.2026.07.027_bib0002","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2003-02-0342","article-title":"Graft-versus-leukemia reactions in allogeneic chimeras","volume":"103","author":"Kolb","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0003","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.07.027_bib0004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.jtct.2026.07.027_bib0005","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0006","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0007","first-page":"973","article-title":"Allogeneic hematopoietic cell donor selection: contemporary Guidelines from the NMDP\/CIBMTR","volume":"31","author":"Shaw","year":"2025","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.027_bib0008","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2014-02-514760","article-title":"Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist","volume":"124","author":"Kekre","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.07.027_bib0010","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.07.027_bib0011","article-title":"Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: follow-up from a national marrow donor program-sponsored prospective clinical trial","volume":"29","author":"Shaw","year":"2023","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.027_bib0012","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/bloodadvances.2024015173","article-title":"Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial","volume":"9","author":"Raiola","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.07.027_bib0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0014","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.07.027_bib0015","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2014.59.1339","article-title":"Prediction of allogeneic hematopoietic stem-cell transplantation mortality 100 days after transplantation using a machine learning algorithm: a European Group for blood and marrow transplantation acute leukemia working party retrospective data mining study","volume":"33","author":"Shouval","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.07.027_bib0016","series-title":"2023 4th International Conference on Communication, Computing and Industry 6.0 (C216)","first-page":"1","article-title":"A review on donor selection in hematopoietic stem cell transplantation (HSCT)","author":"Rashmi","year":"2023"},{"key":"10.1016\/j.jtct.2026.07.027_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13226869","article-title":"A new tool supporting the selection of the best hematopoietic stem cell donor by modelling local own real-world data","volume":"13","author":"Crocchiolo","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtct.2026.07.027_bib0018","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.2024027287","article-title":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","volume":"145","author":"Hern\u00e1ndez-Boluda","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.07.027_bib0019","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1182\/bloodadvances.2024013756","article-title":"Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes","volume":"8","author":"Spellman","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.07.027_bib0020","first-page":"775.e1","article-title":"Predicting patient death after allogeneic stem cell transplantation for inborn errors using machine learning (PREPAD): a European Society for blood and marrow transplantation inborn errors working party study","volume":"29","author":"von Asmuth","year":"2023","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.027_bib0021","unstructured":"Rozemberczki B, Watson L, Bayer P, et al. The Shapley value in machine learning. arXiv:2202.05594v2"},{"key":"10.1016\/j.jtct.2026.07.027_bib0022","series-title":"Survival Analysis","author":"Klein","year":"2003"},{"key":"10.1016\/j.jtct.2026.07.027_bib0023","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10115-013-0679-x","article-title":"Explaining prediction models and individual predictions with feature contributions","volume":"41","author":"\u0160trumbelj","year":"2014","journal-title":"Knowl Inf Syst"},{"key":"10.1016\/j.jtct.2026.07.027_bib0024","unstructured":"Lundberg S, Lee SI. A Unified approach to interpreting model predictions. Advances in Neural Information Processing Systems 30 (NIPS 2017). Available at:https:\/\/papers.nips.cc\/paper_files\/paper\/2017\/file\/8a20a8621978632d76c43dfd28b67767-Paper.pdf"},{"key":"10.1016\/j.jtct.2026.07.027_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jkss.2018.03.002","article-title":"Bayesian methods for dealing with missing data problems","volume":"47","author":"Ma","year":"2018","journal-title":"J Korean Stat Soc"},{"key":"10.1016\/j.jtct.2026.07.027_bib0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B Stat Methodol"},{"key":"10.1016\/j.jtct.2026.07.027_bib0027","series-title":"Bayesian data analysis","author":"Gelman","year":"2013"},{"key":"10.1016\/j.jtct.2026.07.027_bib0028","series-title":"The statistical analysis of failure time data","author":"Kalbfleisch","year":"2002"},{"key":"10.1016\/j.jtct.2026.07.027_bib0029","unstructured":"Hoffman, MD & Gelman, A The no-U-turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. (2011)."},{"key":"10.1016\/j.jtct.2026.07.027_bib0030","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v080.i01","article-title":"brms : an R Package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jtct.2026.07.027_bib0031","series-title":"Regression Modeling Strategies","author":"Harrell","year":"2015"},{"issue":"4","key":"10.1016\/j.jtct.2026.07.027_bib0032","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1541-0420.2007.00832.x","article-title":"Efron-type measures of prediction error for survival analysis","volume":"63","author":"Thomas","year":"2007","journal-title":"Biometrics"},{"key":"10.1016\/j.jtct.2026.07.027_bib0033","series-title":"Dynamic Prediction in Clinical Survival Analysis","author":"van Houwelingen","year":"2011"},{"key":"10.1016\/j.jtct.2026.07.027_bib0034","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2026.07.027_bib0035","first-page":"672.e1","article-title":"Role of donor cytomegalovirus serostatus in cytomegalovirus-seronegative recipients of unrelated donor hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis","volume":"31","author":"Mehta","year":"2025","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.jtct.2026.07.027_bib0036","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cid\/ciz490","article-title":"A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation","volume":"70","author":"Ljungman","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2026.07.027_bib0037","series-title":"shiny: web application framework for R","author":"Chang","year":"2021"},{"key":"10.1016\/j.jtct.2026.07.027_bib0038","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National marrow donor program\u2013sponsored multicenter, phase II Trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2026.07.027_bib0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s44313-025-00081-7","article-title":"CMV infections after HSCT: prophylaxis and treatment","volume":"60","author":"Chung","year":"2025","journal-title":"Blood Res"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726005877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:29:04Z","timestamp":1790249344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726005877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S2666636726005877"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Bayesian Survival Model to Support the Selection of the Best Hematopoietic Stem Cell Donor","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}